Roche Enters Up to $2.3 Billion Global Collaboration with Nurix Therapeutics for BTK Degrader Bexobrutideg

Intelligence Brief:Roche Enters Up to $2.3 Billion Global Collaboration with Nurix Therapeutics for BTK Degrader BexobrutidegJohnson & Johnson Acquires Firefly Bio for $1 Billion to Bolster Oncology Pipeline with Degrader Antibody Conjugate PlatformAscension Health Finalizes $3.9 Billion Amsurg Acquisition After Divesting Seven Surgery Centers to Address FTC Antitrust ConcernsNHS England Accelerates AI AdoptionRolling Out Microsoft 365 Copilot to 505000 Clinicians and Support StaffGoHealthInc. Initiates Chapter 11 Restructuring to Bolster Financial Position Before 2026 Annual Enrollment Period## Healthcare Daily Pulse: Rapid Fire Analysis **Hosts:** * **Alex:** Skeptical Financial Analyst (Payor expert). Technical, critical, implementation-focused. * **Sam:** Optimistic Market Visionary (ROI/Competitive Strategy expert). Pragmatic but forward-looking. --- **(Sound of a fast-paced, high-energy news intro jingle fades slightly under dialogue)** **Sam:** Welcome back to Healthcare Daily Pulse! We're diving deep into the most critical, data-driven developments shaping the healthc...